# A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood

> **NCT06255340** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 75 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 3031185
- **DRUG:** Placebo matching BI 3031185

## Key facts

- **NCT ID:** NCT06255340
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-11
- **Primary completion:** 2024-08-28
- **Final completion:** 2024-08-28
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2024-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06255340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06255340, "A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06255340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*